Search research articles
Contact Us
Filters
Showing results (631-640 of 675) with videos related to
Page
of 68
Sort By:
Scientific Reports
|
February 4, 2022
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies
Maryam Khan, Carolina Rosadas, Ksenia Katsanovskaja, et al.
Maternal and Child Health Journal
|
May 31, 2012
Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction?
S M Boylan, D C Greenwood, N Alwan, et al.
Science (New York, N.Y.)
|
February 8, 2022
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Paul Elliott, Barbara Bodinier, Oliver Eales, et al.
Trials
|
July 19, 2022
Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
I Russel Lee, Steven Y C Tong, Joshua S Davis, et al.
BMJ Health & Care Informatics
|
November 20, 2020
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis research
David Anthony Smith, Tingyan Wang, Oliver Freeman, et al.
European Journal of Epidemiology
|
March 23, 2010
Caffeine intake during pregnancy, late miscarriage and stillbirth
Darren C Greenwood, Nisreen Alwan, Sinead Boylan, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
Cancer Discovery
|
October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Infectious Diseases and Therapy
|
September 27, 2023
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies
Iain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
The Lancet. Microbe
|
August 23, 2021
Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study
Ho Kwong Li, Myrsini Kaforou, Jesus Rodriguez-Manzano, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 675) with videos related to
Sort By:
Page
of 68
Scientific Reports
|
February 4, 2022
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies
Maryam Khan, Carolina Rosadas, Ksenia Katsanovskaja, et al.
Maternal and Child Health Journal
|
May 31, 2012
Does nausea and vomiting of pregnancy play a role in the association found between maternal caffeine intake and fetal growth restriction?
S M Boylan, D C Greenwood, N Alwan, et al.
Science (New York, N.Y.)
|
February 8, 2022
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
Paul Elliott, Barbara Bodinier, Oliver Eales, et al.
Trials
|
July 19, 2022
Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial
I Russel Lee, Steven Y C Tong, Joshua S Davis, et al.
BMJ Health & Care Informatics
|
November 20, 2020
National Institute for Health Research Health Informatics Collaborative: development of a pipeline to collate electronic clinical data for viral hepatitis research
David Anthony Smith, Tingyan Wang, Oliver Freeman, et al.
European Journal of Epidemiology
|
March 23, 2010
Caffeine intake during pregnancy, late miscarriage and stillbirth
Darren C Greenwood, Nisreen Alwan, Sinead Boylan, et al.
Wellcome Open Research
|
August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C
Graham S Cooke, Sarah Pett, Leanne McCabe, et al.
Cancer Discovery
|
October 20, 2023
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
Olivier Nolan-Stevaux, Cong Li, Lingming Liang, et al.
Infectious Diseases and Therapy
|
September 27, 2023
Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies
Iain A Gillespie, Eleanor Barnes, Ian C K Wong, et al.
The Lancet. Microbe
|
August 23, 2021
Discovery and validation of a three-gene signature to distinguish COVID-19 and other viral infections in emergency infectious disease presentations: a case-control and observational cohort study
Ho Kwong Li, Myrsini Kaforou, Jesus Rodriguez-Manzano, et al.
Page
of 68